Is Clofibrate registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 0 valid registrations of Clofibrate.

Is Clofibrate approved by the US FDA?

Drugs@FDA lists 6 application product lines for Clofibrate, including ATROMID-S (Discontinued); CLOFIBRATE (Discontinued); CLOFIBRATE (Discontinued); CLOFIBRATE (Discontinued); CLOFIBRATE (Discontinued).

Active substance

Clofibrate

SFDA 1
US FDA 6

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ATROMID-S CAPSULES 500 MG	500 mg	Capsule · Oral use	50 Blister	SAR 16.75	NCE · Prescription	AstraZeneca	Withdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

Product	Strength	Form · route	Applicant	Status	First approved
ATROMID-S	500MG	capsule · oral	WYETH AYERST	Discontinued	8 Feb 1967
CLOFIBRATE	500MG	capsule · oral	USL PHARMA	Discontinued	16 Jun 1986
CLOFIBRATE	500MG	capsule · oral	WATSON LABS	Discontinued	18 Sep 1987
CLOFIBRATE	500MG	capsule · oral	TEVA	Discontinued	25 Jul 1991
CLOFIBRATE	500MG	capsule · oral	BANNER PHARMACAPS	Discontinued	20 Mar 1992
CLOFIBRATE	500MG	capsule · oral	SANDOZ	Discontinued

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.